期刊文献+

Surface modified solid lipid microparticles based on homolipids and Softisan 142:preliminary characterization

下载PDF
导出
摘要 ObjectiveTo preliminarily investigate three different lipid matrices consisting of two natural homolipids from Capra hircus (goat fat) and Bovine Spp. (tallow fat) and one semi-synthetic lipid (Softisan? 142) separately structured with Phospholipon? 90G (P90G) as potential delivery systems for poorly water soluble drugs.MethodsThe structured lipid matrices were characterized by differential scanning calorimetry (DSC) and employed to prepare solid lipid microparticles (SLMs) by the melt homogenization method using gradient concentrations of polysorbate 80 and at different emulsification times of 2, 5 and 10 min using a Silverson mixer. The SLMs were analyzed for morphology and particle size, thermal properties, stability studies and determination of injectability.ResultsThe results showed that SLM production was optimum at 5 % of lipid matrices, 1.5 % of polysorbate 80 and emulsification time of 5 min. Increase in polysorbate 80 concentrations decreased the particle size of the SLMs. The SLMs were well formed, spherical, smooth and non-porous with particle sizes in the ranges of (13.90 ± 2.10) μm - (0.09 ± 0.01) μm for SLMs produced from the structured - tallow fat; (13.40 ± 1.30) μm - (0.10 ± 0.01) μm for the structured - goat fat and (13.40±2.00) μm - (2.10± 1.00)μm for the structured Softisan? 142 lipid matrices. DSC traces showed that Softisan? 142 was the most crystalline of all three bulk matrices due to its high enthalpy (?7.962 mW/mg) while tallow fat was the least (?5.067 mW/mg) but addition of P90G to the matrices lowered their enthalpies mostly in the structured goat fat matrices. The SLMs when stored at 4-6 ° were most stable and syringeable with 27 G needle.ConclusionsThis suggests that structured goat fat matrices with the enthalpy of ?2.813 mW/mg will mostly favour drug loading of some poorly soluble drugs more than tallow fat (?4.892 mW/mg) and Softisan? 142 (?5.501 mW/mg). <正>Objective:To preliminarily investigate three different lipid matrices consisting of two natural homolipids from Capra hircus(goat fat) and Bovine Spp.(tallow fat) and one semi-synthetic lipid(Softisan~? 142) separately structured with Phospholipon~? 90G(P90G) as potential delivery systems for poorly water soluble drugs.Methods:The structured lipid matrices were characterized by differential scanning calorimetry(DSC) and employed to prepare solid lipid microparticles(SLMs) by the melt homogenization method using gradient concentrations of polysorbate 80 and at different emulsification times of 2,5 and 10 min using a Silverson mixer. The SLMs were analyzed for morphology and particle size,thermal properties,stability studies and determination of injectability.Results:The results showed that SLM production was optimum at 5%of lipid matrices,1.5%of polysorbate 80 and emulsification time of 5 min.Increase in polysorbate 80 concentrations decreased the particle size of the SLMs.The SLMs were well formed, spherical,smooth and non-porous with particle sizes in the ranges of(13.90±2.10)μm -(0.09±0.01)μm for SLMs produced from the structured - tallow fat;(13.40±1.30)μm-(0.10±0.01)μm for the structured - goat fat and(13.40±2.00)μm-(2.10±1.00)μm for the structured Softisan~? 142 lipid matrices.DSC traces showed that Softisan~? 142 was the most crystalline of all three bulk matrices due to its high enthalpy(-7.962 mW/mg) while tallow fat was the least(-5.067 mW/mg) but addition of P90G to the matrices lowered their enthalpies mostly in the structured goat fat matrices.The SLMs when stored at 4-6°C were most stable and syringeable with 27 G needle.Conclusions:This suggests that structured goat fat matrices with the enthalpy of -2.813 mW/mg will mosdy favour drug loading of some poorly soluble drugs more than tallow fat(-4.892 mW/mg) and Softisan? 142(-5.501 mW/mg).
出处 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2010年第3期205-210,共6页 亚太热带医药杂志(英文版)
  • 相关文献

参考文献16

  • 1Weir,C.E. Fat Content and Composition of Animal Products . 1976
  • 2AA Attama,IT Nzekwe,PO Nnamani,MU Adikwu,CO Onugu.The use of solid self-emulsifying systems in the delivery of diclofenac. International Journal of Pharmaceutics . 2003
  • 3Attama AA,Nkemnele MO.In vitro evaluation of drug release from self micro-emulsifying drug delivery systems using a biodegradable homolipid from Capra hircus. International Journal of Pharmaceutics . 2005
  • 4A Radomska-Soukharev.Stability of lipid excipient in solid lipid nanoparticles. Advanced Drug Delivery Reviews . 2007
  • 5M Schubert,B Schicke,CC Mueller-Goymann.Thermal analysis of the crystallization and melting behavior of lipid matrices and lipid nanoparticles containing high amounts of lecithin. International Journal of Pharmaceutics . 2005
  • 6Reithmeier,H.,Herrmann,J.,Gopferich,A.Development and characterization of lipid microparticles as a drug carrier for somatostatin. International Journal of Pharmaceutics . 2001
  • 7S Jaspart,P Bertholet,G Piel,JM Dogné,L Delattre,B Evrard.Solid lipid microparticles as a sustained release system for pulmonary drug delivery. European Journal of Pharmaceutics and Biopharmaceutics . 2007
  • 8V Sanna,N Kirschvink,P Gustin,E Gavini,I Roland,L Delattre.Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration. AAPS PharmSciTech . 2003
  • 9BD Kim,K Na,HK Choi.Preparation and characterization of solid lipid nanoparticles (SLN) made of cacao butter and curdlan. European Journal of Pharmaceutical Sciences . 2005
  • 10S Jaspart,G Piel,L Delattre,B Evrard.Solid lipid microparticles: formulation, preparation, characterization, drug release and applications. Expert Opin Drug Deliv . 2005

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部